[1] |
Yang Ji, Xu Xinzhi, Li Ming.
Early diagnosis of dermatomyositis and early recognition of visceral injury
[J]. Chinese Journal of Dermatology, 2023, 56(2): 161-164.
|
[2] |
Zhan Jinshan, Xuan Xiuyun, Cao Juanmei, Chen Fangqi, Huang Changzheng.
Progress in treatment of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
[J]. Chinese Journal of Dermatology, 2023, 0(2): 20220368-e20220368.
|
[3] |
Ye Jiaqi, Chai Weimin, Zheng Jie, Cao Hua.
Evaluation of dermatomyositis complicated by interstitial lung disease based on skin lesions, serum biomarkers and radiological features
[J]. Chinese Journal of Dermatology, 2023, 0(2): 20220388-e20220388.
|
[4] |
Zhang Shimin, Hu Yunyun, Zhao Xiaoqing, Du Lianjun, Cao Hua, Zheng Jie.
Application of imaging techniques in diagnosis and severity assessment of dermatomyositis
[J]. Chinese Journal of Dermatology, 2022, 55(7): 637-640.
|
[5] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Cyclosporine in the treatment of immune-related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479.
|
[6] |
Lyu Ling, Lyu Xiaoyan.
Dermatomyositis with malignancy: an update
[J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279.
|
[7] |
Cao Hua, Zheng Jie .
Evolution of diagnostic criteria for clinically amyopathic dermatomyositis
[J]. Chinese Journal of Dermatology, 2022, 55(11): 1008-1013.
|
[8] |
Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases.
Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis (2022)
[J]. Chinese Journal of Dermatology, 2022, 55(11): 939-949.
|
[9] |
Yang Ji, Xu Xinzhi, Li Ming.
Pseudoangioedema: a new type of skin lesions of dermatomyositis
[J]. Chinese Journal of Dermatology, 2022, 55(11): 1019-1020.
|
[10] |
Autoimmune Disease Group, China Dermatologist Association.
Chinese expert consensus on cyclophosphamide for the treatment of autoimmune dermatoses
[J]. Chinese Journal of Dermatology, 2021, 54(9): 765-770.
|
[11] |
Yang Changzhi, Zhang Xiaoping, Yang Ziliang, Zhou Naihui, Zhu Liping, Shao Kai, Zhu Tingting, Yu Xiuqin.
Association of antinuclear antibody status with clinical features and malignancy risk in adult patients with dermatomyositis
[J]. Chinese Journal of Dermatology, 2021, 54(6): 480-484.
|
[12] |
Hua Weiwei, Gong Chunyan.
Application of JAK inhibitors in the treatment of refractory dermatomyositis
[J]. Chinese Journal of Dermatology, 2021, 54(3): 264-267.
|
[13] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Azathioprine in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2021, 54(2): 116-121.
|
[14] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Mycophenolate mofetil in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2020, 53(11): 869-874.
|
[15] |
Xue Ke, Quan Cheng, Zhao Qian, Diao Licheng, Chen Mengya, Zhu Xuemei, Zheng Jie, Cao Hua, Li Hao .
Differentially expressed genes in peripheral blood of patients with dermatomyositis complicated by interstitial lung disease or malignant tumors
[J]. Chinese Journal of Dermatology, 2020, 53(1): 23-29.
|